Ticker >

EP Biocomposites share price

EP Biocomposites Ltd.

BSE: 543595 SECTOR: Plastic Products  23k   4   0

178.50
-2.35 (-1.30%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 178.65

Today's Low

₹ 178.4

52 Week High

₹ 254

52 Week Low

₹ 171

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

30.01 Cr.

Enterprise Value

29.1 Cr.

No. of Shares

0.17 Cr.

P/E

52.1

P/B

3.57

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  50.04

CASH

2.19 Cr.

DEBT

1.28 Cr.

Promoter Holding

70.08 %

EPS (TTM)

₹  3.43

Sales Growth

-11.52%

ROE

11.07 %

ROCE

13.21%

Profit Growth

-28.82 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-11.52%
3 Year132.4%
5 YearNA

Profit Growth

1 Year-28.82%
3 Year163.47%
5 YearNA

ROE%

1 Year11.07%
3 Year83.82%

ROCE %

1 Year13.21%
3 Year92.66%

Debt/Equity

0.1523

Price to Cash Flow

-37.79

Interest Cover Ratio

4.54066985645933

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 70.08 0
Sep 2023 70.08 0
Mar 2023 70.08 0
Sep 2022 69.31 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 132.398949068903% for the Past 3 years.
  • The company has significantly decreased its debt by 2.8294 Cr.
  • Company has been maintaining healthy ROE of 83.8241359097125% over the past 3 years.
  • Company has been maintaining healthy ROCE of 92.6593367256079% over the past 3 years.
  • Company has a healthy liquidity position with current ratio of 4.45088899567516.
  • The company has a high promoter holding of 70.08%.

 Limitations

  • Company has high debtor days of 331.631584113984.
  • Company has negative cash flow from operations of -0.7942.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high PE of 52.1.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 0.57 2.95 8.06 7.13
Total Expenditure 0.52 2.49 6.65 6.15
Operating Profit 0.04 0.46 1.41 0.98
Other Income 0 0 0.02 0.17
Interest 0 0 0.19 0.23
Depreciation 0 0 0.07 0.1
Exceptional Items 0 0 0 0
Profit Before Tax 0.04 0.46 1.17 0.81
Tax 0.01 0.11 0.36 0.24
Net Profit 0.03 0.36 0.81 0.58
Adjusted EPS (Rs.) 0.84 9.55 6.87 3.43

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 0.05 0.05 1.18 1.68
Total Reserves -0.02 0.34 0.82 6.73
Borrowings 0 0 2.18 1.2
Other N/C liabilities 0 0 0.14 0.03
Current liabilities 0.52 0.94 4.96 2.08
Total Liabilities 0.55 1.32 9.28 11.72
Assets
Net Block 0 0 0.41 0.33
Capital WIP 0 0 0 0
Intangible WIP 0 0 0 0
Investments 0 0 0 0
Loans & Advances 0 0 0.06 2.12
Other N/C Assets 0 0.02 0.23 0.01
Current Assets 0.55 1.3 8.58 9.26
Total Assets 0.55 1.32 9.28 11.72
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.04 0.46 1.17 0.81
Adjustment 0 0 0.22 0.26
Changes in Assets & Liabilities 0.07 -0.42 -5.5 -1.5
Tax Paid 0 -0.01 -0.16 -0.36
Operating Cash Flow 0.12 0.03 -4.28 -0.79
Investing Cash Flow 0 0 -0.47 0.02
Financing Cash Flow 0 0 4.76 2.81
Net Cash Flow 0.12 0.03 0.01 2.04

Corporate Actions

Investors Details

PARTICULARS Sep 2022% Mar 2023% Sep 2023% Dec 2023%
promoters 69.31 70.08 70.08 70.08
ashma rajkumar kamat 0.31 0.31 0.31 0.31
leena rajkumar kamat 64.93 64.93 - 64.93
nimisha rajkumar kamat 0.31 0.84 - 0.84
rajkumar gajanan kamat 3.76 3.99 - 3.99
leena rajkumar kamat . - - 64.93 -
nimisha rajkumar kamat . - - 0.84 -
rajkumar gajanan kamat . - - 3.99 -
PARTICULARS Sep 2022% Mar 2023% Sep 2023% Dec 2023%
investors 30.69 29.92 29.92 29.92
nav capital vcc - nav cap... 1.19 2.20 2.20 2.20
talib zafar - - 1.10 1.07
xtended business reportin... - 1.55 1.40 -
mayuri shripal vora - 1.01 - -
talib zafar 1.25 1.07 - -
sanjay popatlal jain 2.97 - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

EP Biocomposites Stock Price Analysis and Quick Research Report. Is EP Biocomposites an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). EP Biocomposites has a PE ratio of 52.1000554566417 which is high and comparatively overvalued .

  • Share Price: - The current share price of EP Biocomposites is Rs 178.5. One can use valuation calculators of ticker to know if EP Biocomposites share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. EP Biocomposites has ROA of 5.48664053980695 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. EP Biocomposites has a Current ratio of 4.45088899567516 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. EP Biocomposites has a ROE of 11.0652274124155 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. EP Biocomposites has a D/E ratio of 0.1523 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. EP Biocomposites has an Inventory turnover ratio of 6.48667333757846 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - EP Biocomposites has reported revenue growth of -11.5241451188645 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of EP Biocomposites for the current financial year is 13.7053346048129 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for EP Biocomposites is Rs 0 and the yield is 0 %.

Last Updated on:
Brief about EP Biocomposites
X